We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
Cap. Flow
+$156M
Cap. Flow %
7.83%
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294

Top Buys

Rank Stock Value
1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$8.42M
2
MPC icon
Marathon Petroleum
MPC
+$5.47M
3
LBTYK icon
Liberty Global Class C
LBTYK
+$5.39M
4
ORLY icon
O'Reilly Automotive
ORLY
+$5.32M
5
CROX icon
Crocs
CROX
+$5.07M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$12.6M
2
TPR icon
Tapestry
TPR
+$12M
3
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$8.32M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$6.96M
5
SAGE
Sage Therapeutics
SAGE
+$6.93M

Sector Composition

Rank Sector Weight
1 Healthcare 2.95%
2 Consumer Discretionary 2.51%
3 Technology 1.96%
4 Energy 1.43%
5 Communication Services 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNW
401
CALL
DELISTED
Light & Wonder
LNW
$843K 0.04%
42,500
-77,500
-65% -$1.6M
TYPE
402
PUT
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$843K 0.04%
+50,000
New +$891K
HUN icon
403
CALL
Huntsman Corp
HUN
$1.71B
$817K 0.04%
+40,000
New +$840K
PTCT icon
404
PUT
PTC Therapeutics
PTCT
$5.68B
$811K 0.04%
18,000
-18,000
-50% -$711K
RAD
405
CALL
DELISTED
Rite Aid Corporation
RAD
$801K 0.04%
+100,000
New +$862K
RAD
406
DELISTED
Rite Aid Corporation
RAD
$801K 0.04%
+100,000
New +$862K
RAD
407
PUT
DELISTED
Rite Aid Corporation
RAD
$801K 0.04%
+100,000
New +$862K
NVRO
408
DELISTED
NEVRO CORP.
NVRO
$798K 0.04%
12,300
-17,700
-59% -$1.1M
HGV icon
409
CALL
Hilton Grand Vacations
HGV
$3.59B
$795K 0.04%
25,000
-50,000
-67% -$1.49M
ATNX
410
PUT
DELISTED
Athenex, Inc. Common Stock
ATNX
$792K 0.04%
+2,000
New +$554K
ET icon
411
Energy Transfer Partners
ET
$70.1B
$788K 0.04%
56,000
-44,000
-44% -$651K
INSM icon
412
Insmed
INSM
$21.4B
$768K 0.04%
30,000
-47,500
-61% -$1.32M
DISH
413
CALL
DELISTED
DISH Network Corp.
DISH
$768K 0.04%
+20,000
New +$710K
BLUE
414
DELISTED
bluebird bio
BLUE
$763K 0.04%
+463
New +$801K
STAY
415
PUT
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$760K 0.04%
45,000
– –
EQT icon
416
EQT Corp
EQT
$33.3B
$759K 0.04%
+48,000
New +$921K
NBIS
417
CALL
Nebius Group N.V.
NBIS
$48.3B
$759K 0.04%
20,000
– –
BOLD
418
DELISTED
Audentes Therapeutics, Inc
BOLD
$757K 0.04%
+20,000
New +$768K
PARA
419
DELISTED
Paramount Global Class B
PARA
$749K 0.04%
+15,000
New +$742K
NEOG icon
420
Neogen
NEOG
$2.63B
$746K 0.04%
+24,000
New +$707K
AXTA icon
421
CALL
Axalta
AXTA
$7.66B
$745K 0.04%
+25,000
New +$663K
GNW icon
422
Genworth Financial
GNW
$3.76B
$742K 0.04%
+200,000
New +$709K
DAL icon
423
CALL
Delta Air Lines
DAL
$57.5B
$738K 0.04%
+13,000
New +$728K
SVRA icon
424
CALL
Savara
SVRA
$1.12B
$736K 0.04%
+310,500
New +$2.76M
IOVA icon
425
CALL
Iovance Biotherapeutics
IOVA
$1.82B
$735K 0.04%
+30,000
New +$452K
15 16
17
18 19

Similar funds

ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Caption Management's Q2 2019 Portfolio in Review

As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.

By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.

  • Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
  • Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
  • Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
  • Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
  • Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
  • Caption Management opened 395 new positions and closed 294 in Q2 2019.
  • Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.

Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.